ICD-10 Coding for Breast Cancer with Metastasis(C50.0, C50.212, C50.911)
Learn about ICD-10 coding for breast cancer with metastasis, including primary and secondary codes, documentation requirements, and common pitfalls.
Complete code families applicable to Breast Cancer with Metastasis
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C50.911 | Malignant neoplasm of unspecified site of right female breast | Use when the primary site of breast cancer is the right breast and specific site is not documented. |
|
| C79.51 | Secondary malignant neoplasm of bone | Use when there is confirmed metastasis to the bone. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutBreast Cancer with Metastasis
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Breast Cancer with Metastasis.
Vague documentation of metastasis
Impact
Clinical: Inaccurate treatment planning, Regulatory: Non-compliance with coding standards, Financial: Potential for denied claims
Mitigation
Use specific terms for metastasis sites, Ensure documentation includes imaging and biopsy results
Incorrect sequencing of primary and secondary codes.
Impact
Reimbursement: Incorrect DRG assignment leading to potential underpayment., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation
Sequence the secondary site first if treatment focuses on metastasis.
Metastasis documentation
Impact
Inadequate documentation of metastasis sites.
Mitigation
Ensure all imaging and biopsy results are documented.